Does the nonsense‐mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

The nonsense‐mediated mRNA decay (NMD) mechanism is an evolutionarily conserved process ensuring the degradation of transcripts carrying premature termination codon(s). NMD is believed to prevent the synthesis of truncated proteins that could be detrimental to the cell. However, although numerous studies have assessed the efficiency of this mechanism at the mRNA level, data are lacking in regard to whether NMD fulfills its expected goal at the protein level. In this study, we have investigated whether endogenous alleles of breast cancer predisposing genes carrying nonsense codons were able to produce detectable amounts of truncated proteins in lymphoblastoid cell lines. A total of 20 truncating BRCA1 mutations were analyzed, along with the 1100delC CHEK2 and the 770delT TP53 mutations. All the studied alleles triggered NMD, the amount of mutant transcript ranging from 16 to 63% of that of the wild‐type species. We found that BRCA1 and CHK2 truncated proteins could not be detected, even when NMD was inhibited. This suggests that BRCA1 and CHK2 truncated proteins are highly unstable. Conversely, the p53 protein encoded by the 770delT allele is as abundant as the wild‐type protein, as removal of the C‐terminal p53 domain leads to a stabilized mutant protein, whose abundance is markedly increased when NMD is inhibited. Therefore, our results show that it is not possible to infer the presence of truncated proteins in cells from carriers of a truncated mutation without experimental verification, as each case is expected to be different. Hum Mutat 29(1), 65–73, 2008. © 2007 Wiley‐Liss, Inc.

[1]  Olga Anczuków,et al.  The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon , 2006, Human mutation.

[2]  H. Nevanlinna,et al.  The CHEK2 gene and inherited breast cancer susceptibility , 2006, Oncogene.

[3]  R. Eeles,et al.  Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. , 2006, Cancer research.

[4]  D. Dickson,et al.  Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD) , 2006, Neurobiology of Disease.

[5]  J. Lupski,et al.  Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease , 2006, European Journal of Human Genetics.

[6]  B. Bembi,et al.  Identification of nine new IDS alleles in mucopolysaccharidosis II. Quantitative evaluation by real-time RT-PCR of mRNAs sensitive to nonsense-mediated and nonstop decay mechanisms. , 2006, Biochimica et biophysica acta.

[7]  Y. Kajiwara,et al.  Monoallelic BUB1B mutations and defective mitotic‐spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome , 2006, American journal of medical genetics. Part A.

[8]  S. Tavtigian,et al.  Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? , 2006, Oncogene.

[9]  Sikandar G. Khan,et al.  Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. , 2006, Carcinogenesis.

[10]  David P Lane,et al.  p53 isoforms can regulate p53 transcriptional activity. , 2005, Genes & development.

[11]  S. Ellard,et al.  The position of premature termination codons in the hepatocyte nuclear factor −1 beta gene determines susceptibility to nonsense-mediated decay , 2005, Human Genetics.

[12]  E. Conti,et al.  Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. , 2005, Current opinion in cell biology.

[13]  M. Gonzalès,et al.  Expression of mutant JAGGED1 alleles in patients with Alagille syndrome , 2005, Human Genetics.

[14]  A. Spurdle,et al.  Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals , 2005, British Journal of Cancer.

[15]  S. Geisler,et al.  Alternative splicing and mutation status of CHEK2 in stage III breast cancer , 2004, Oncogene.

[16]  Francisco Martinez-Murillo,et al.  Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise , 2004, Nature Genetics.

[17]  A. Choudhury,et al.  Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression* , 2004, Journal of Biological Chemistry.

[18]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[19]  T. Ohnishi,et al.  Inhibition of nonsense‐mediated mRNA decay rescues the phenotype in Ullrich's disease , 2004, Annals of neurology.

[20]  D. Stoppa-Lyonnet,et al.  Analysis of the allele‐specific expression of the mismatch repair gene MLH1 using a simple DHPLC‐Based Method , 2004, Human mutation.

[21]  J. Lupski,et al.  Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.

[22]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Bertini,et al.  Effects on Collagen VI mRNA Stability and Microfibrillar Assembly of Three COL6A2 Mutations in Two Families with Ullrich Congenital Muscular Dystrophy* , 2002, The Journal of Biological Chemistry.

[24]  D. Stoppa-Lyonnet,et al.  The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. , 2002, Human molecular genetics.

[25]  J. Mendell,et al.  Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense Transcripts , 2002, Science.

[26]  Y. Taya,et al.  Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. , 2001, Genes & development.

[27]  Jing Chen,et al.  Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.

[28]  L. Neckers,et al.  Regulation of BRCA1 by protein degradation , 1999, Oncogene.

[29]  M. Hentze,et al.  Binary specification of nonsense codons by splicing and cytoplasmic translation , 1998, The EMBO journal.

[30]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[31]  A Estreicher,et al.  The human tumour suppressor gene p53 is alternatively spliced in normal cells. , 1996, Oncogene.

[32]  S. Schraub,et al.  Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. , 1994, Oncogene.